PATENT CLAIM ANALYSIS

Application Number: 16141233
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "130100"]

Abstract:
A method of treating a subject suffering from an allergic disorder is provided, the method including inducing rapid desensitization to an allergen, the rapid desensitization effectuated by: administering to the subject a plurality of equal doses of a first anti-FcϵRIα monoclonal antibody, wherein the plurality of equal doses are administered over a 6 to 8 hour period and wherein each dose is lower than a level required to induce shock, thereby inducing rapid desensitization to the allergen. Monoclonal antibodies and methods of co-administering or consecutively administering a combination thereof to effectuate rapid desensitization are also provided.

Claim (Index 18):
The method of  claim 17 , wherein the second anti-Fc\u03f5RI\u03b1 monoclonal antibody is IB10.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 1.68852
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15836095', '14111208', '14633305', '14906026', '13319074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7390578338305366
- 35 USC 102 Novelty (BERT): 0.6519683313778284
- Combined Prediction Score: 0.7303488835852657
- Mean Citation Score: 406.729062
- Max Citation Score: 658.4438
- Similarity Product: 571.1436827564239

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test